Designed Angiopoietin-1 Variant, COMP-Ang1, Protects Against Radiation-induced Endothelial Cell Apoptosis

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2004 Apr 3

PMID 15060280

Citations 50

Authors

Chung-Hyun Cho

Richard A Kammerer

Hyuek Jong Lee

Kunio Yasunaga

Kyung-Tae Kim

Han-Ho Choi

Won Kim

Sung Hyun Kim

Sung Kwang Park

Gyun Min Lee

Gou Young Koh

Affiliations

Soon will be listed here.

Abstract

Radiation therapy is a widely used cancer treatment, but it causes side effects even when localized radiotherapy is used. Extensive apoptosis of microvascular endothelial cells of the lamina propria is the primary lesion initiating intestinal radiation damage after abdominal radiation therapy. Many in vitro studies suggest that angiopoietin-1 (Ang1) has potential therapeutic applications in enhancing endothelial cell survival. For in vivo use, we developed a soluble, stable, and potent Ang1 variant, COMP-Ang1. COMP-Ang1 is more potent than native Ang1 in phosphorylating the Tie2 receptor in lung endothelial cells in vivo. Interestingly, COMP-Ang1 administered i.v. was mainly localized to microvascular endothelial cells of the intestinal villi and lung but not to microvascular endothelial cells of the liver. In irradiated mice, i.v. COMP-Ang1 protected against radiation-induced apoptosis in microcapillary endothelial cells of the intestinal villi and prolonged survival. Thus, COMP-Ang1 could be used as a therapeutic protein for specific protection against endothelial cell injury.

Citing Articles

Radiation-Induced Intestinal Injury: Injury Mechanism and Potential Treatment Strategies.

Lu Q, Liang Y, Tian S, Jin J, Zhao Y, Fan H Toxics. 2023; 11(12).

PMID: 38133412 PMC: 10747544. DOI: 10.3390/toxics11121011.

Cationic LNP-formulated mRNA expressing Tie2-agonist in the lung endothelium prevents pulmonary vascular leakage.

Radloff K, Gutbier B, Dunne C, Moradian H, Schwestka M, Gossen M Mol Ther Nucleic Acids. 2023; 34:102068.

PMID: 38034031 PMC: 10682670. DOI: 10.1016/j.omtn.2023.102068.

Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential diagnosis.

Moreno-Castano A, Fernandez S, Ventosa H, Palomo M, Martinez-Sanchez J, Ramos A J Immunother Cancer. 2023; 11(4).

PMID: 37045474 PMC: 10106034. DOI: 10.1136/jitc-2022-006365.

Early vascular endothelial complications after hematopoietic cell transplantation: Role of the endotheliopathy in biomarkers and target therapies development.

Moreno-Castano A, Salas M, Palomo M, Martinez-Sanchez J, Rovira M, Fernandez-Aviles F Front Immunol. 2022; 13:1050994.

PMID: 36479117 PMC: 9720327. DOI: 10.3389/fimmu.2022.1050994.

Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer.

Khan K, Wu F, Cruz-Munoz W, Kerbel R EMBO Mol Med. 2021; 13(7):e08253.

PMID: 34125494 PMC: 8261516. DOI: 10.15252/emmm.201708253.

References

Jones N, Master Z, Jones J, Bouchard D, Gunji Y, Sasaki H . Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration. J Biol Chem. 1999; 274(43):30896-905. DOI: 10.1074/jbc.274.43.30896. View

Paris F, Fuks Z, Kang A, Capodieci P, Juan G, Ehleiter D . Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science. 2001; 293(5528):293-7. DOI: 10.1126/science.1060191. View

Stoeltzing O, Ahmad S, Liu W, McCarty M, Wey J, Parikh A . Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors. Cancer Res. 2003; 63(12):3370-7. View

Suri C, Jones P, Patan S, Bartunkova S, Maisonpierre P, Davis S . Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 1996; 87(7):1171-80. DOI: 10.1016/s0092-8674(00)81813-9. View

Chae J, Kim I, Lim S, Chung M, Kim W, Kim H . Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol. 2000; 20(12):2573-8. DOI: 10.1161/01.atv.20.12.2573. View

Jones N, Iljin K, Dumont D, Alitalo K . Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol. 2001; 2(4):257-67. DOI: 10.1038/35067005. View

Wong A, Haroon Z, Werner S, Dewhirst M, Greenberg C, Peters K . Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res. 1997; 81(4):567-74. DOI: 10.1161/01.res.81.4.567. View

Kwak H, Lee S, Lee Y, Ryu C, Koh K, Choi H . Angiopoietin-1 inhibits irradiation- and mannitol-induced apoptosis in endothelial cells. Circulation. 2000; 101(19):2317-24. DOI: 10.1161/01.cir.101.19.2317. View

Yancopoulos G, Davis S, Gale N, Rudge J, Wiegand S, Holash J . Vascular-specific growth factors and blood vessel formation. Nature. 2000; 407(6801):242-8. DOI: 10.1038/35025215. View

10.

Takakura N, Watanabe T, Suenobu S, Yamada Y, Noda T, Ito Y . A role for hematopoietic stem cells in promoting angiogenesis. Cell. 2000; 102(2):199-209. DOI: 10.1016/s0092-8674(00)00025-8. View

11.

Shyu K, Manor O, Magner M, Yancopoulos G, Isner J . Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation. 1998; 98(19):2081-7. DOI: 10.1161/01.cir.98.19.2081. View

12.

Thurston G, Suri C, Smith K, McClain J, Sato T, Yancopoulos G . Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science. 2000; 286(5449):2511-4. DOI: 10.1126/science.286.5449.2511. View

13.

Tian S, Hayes A, Li L . Stabilization of breast cancer xenograft tumour neovasculature by angiopoietin-1. Br J Cancer. 2002; 86(4):645-51. PMC: 2375288. DOI: 10.1038/sj.bjc.6600082. View

14.

Veikkola T, Alitalo K . VEGFs, receptors and angiogenesis. Semin Cancer Biol. 1999; 9(3):211-20. DOI: 10.1006/scbi.1998.0091. View

15.

Sato T, Qin Y, Kozak C, Audus K . Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc Natl Acad Sci U S A. 1993; 90(20):9355-8. PMC: 47566. DOI: 10.1073/pnas.90.20.9355. View

16.

Hawighorst T, Skobe M, Streit M, Hong Y, Velasco P, Brown L . Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth. Am J Pathol. 2002; 160(4):1381-92. PMC: 1867215. DOI: 10.1016/S0002-9440(10)62565-5. View

17.

Kim I, Kim H, So J, Kim J, Kwak H, Koh G . Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway. Circ Res. 2000; 86(1):24-9. DOI: 10.1161/01.res.86.1.24. View

18.

Thurston G, Rudge J, Ioffe E, Zhou H, Ross L, Croll S . Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med. 2000; 6(4):460-3. DOI: 10.1038/74725. View

19.

Okunieff P, Mester M, Wang J, Maddox T, Gong X, Tang D . In vivo radioprotective effects of angiogenic growth factors on the small bowel of C3H mice. Radiat Res. 1998; 150(2):204-11. View

20.

Kim I, Kim H, Moon S, Chae S, So J, Koh K . Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. Circ Res. 2000; 86(9):952-9. DOI: 10.1161/01.res.86.9.952. View